Pfizer director granted 1,595 phantom stock units

Quincey James reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Quincey James reported acquisition or exercise transactions in this Form 4 filing.

Pfizer director James Quincey received a grant of 1,595.307 Phantom Stock Units linked to Pfizer common stock. The units were valued at $24.29 each and increase his deferred Phantom Stock Unit balance to 87,993.957 units following the transaction.

Each unit represents one phantom share of common stock and forms part of deferred director compensation, including dividend equivalents. These amounts are to be settled in cash or common stock, at the director's election, after he retires from Pfizer’s Board of Directors.

Insider Trade Summary

Grant/Award: 1,595.307 shares

Grant/Award 1 txn

Insider Quincey James

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	1,595.307	$24.29	$39K

Holdings After Transaction: Phantom Stock Units — 87,993.957 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom Stock Units granted: 1,595.307 units Unit reference value: $24.29 per unit Total Phantom Stock Units after grant: 87,993.957 units +1 more

4 metrics

Phantom Stock Units granted 1,595.307 units Grant of Phantom Stock Units on June 26, 2026

Unit reference value $24.29 per unit Recorded value per Phantom Stock Unit for this grant

Total Phantom Stock Units after grant 87,993.957 units Director’s Phantom Stock Unit balance following transaction

Underlying common stock link 1 unit = 1 share Each unit represents one phantom share of common stock

Key Terms

Phantom Stock Units, deferred director's compensation, dividend equivalents, settled in cash or common stock

4 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

deferred director's compensation financial

"These units represent deferred director's compensation (including dividend equivalents thereon)..."

dividend equivalents financial

"These units represent deferred director's compensation (including dividend equivalents thereon)..."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

settled in cash or common stock financial

"…that are settled in cash or common stock at the director's election…"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) report for James Quincey?

Pfizer reported that director James Quincey received 1,595.307 Phantom Stock Units as deferred compensation. Each unit tracks one share of Pfizer common stock and is part of his long-term director compensation program.

What are Phantom Stock Units in the Pfizer (PFE) Form 4 filing?

Phantom Stock Units are bookkeeping units, each representing one phantom share of Pfizer common stock. They reflect deferred director compensation and dividend equivalents, and are settled later in cash or common stock rather than through immediate stock issuance.

At what value were James Quincey’s Pfizer Phantom Stock Units recorded?

The 1,595.307 Phantom Stock Units granted to James Quincey were recorded at $24.29 per unit. This establishes the reference value for this deferred compensation award tied to Pfizer’s common stock performance.

How many Pfizer Phantom Stock Units does James Quincey hold after this transaction?

After this grant, James Quincey holds a total of 87,993.957 Phantom Stock Units. This balance represents accumulated deferred director compensation, including dividend equivalents, to be settled after he retires from the Pfizer Board.

When will James Quincey’s Pfizer Phantom Stock Units be settled?

The Phantom Stock Units will be settled after James Quincey retires from Pfizer’s Board of Directors. At that time, he may elect to receive settlement in either cash or Pfizer common stock, according to the plan’s terms.

Does the Pfizer (PFE) Form 4 show a stock purchase or sale by James Quincey?

The Form 4 does not show an open-market stock purchase or sale by James Quincey. It reports a grant of Phantom Stock Units as deferred director compensation, a routine, non-market transaction settled in the future.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 03:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Quincey James

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	06/26/2026		A		1,595.307		(2)	(2)	Common Stock	1,595.307	$24.29	87,993.957	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for James Quincey	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)